Answers are grounded in this paper and cite their sources.
Background/Objectives: Treatment for drug-resistant tuberculosis involves a long duration and a heavy burden of drug-induced hepatotoxicity; drug-induced liver injury (DILI) is a significant issue affecting treatment safety. The Dietary Inflammation Index (DII) quantifies the pro-inflammatory potential of the diet, but evidence linking it to the risk of DILI in patients with drug-resistant tuberculosis is limited. This study aimed to investigate the relationship between DII and the risk of treatment-related liver injury in patients with drug-resistant tuberculosis. Methods: A prospective cohort of patients with drug-resistant tuberculosis was established at Hunan Provincial Chest Hospital, with a 6-month follow-up period during which liver function was assessed monthly. DILI was identified based on liver function abnormalities and causality was assessed using the Roussel Uclaf Causality Assessment Method (RUCAM), with a RUCAM score > 3 considered indicative of DILI. The Dietary Inflammatory Index (DII) was calculated using a semi-quantitative food frequency questionnaire, and participants were classified into anti-inflammatory, neutral, and pro-inflammatory groups using K-means clustering. Logistic regression was used to evaluate the association between DII and DILI after adjustment for potential confounders, including age, sex, BMI, smoking, alcohol consumption, and medication use. L1 regularization, restricted cubic spline analysis, and subgroup analyses were further performed to assess the robustness and potential nonlinear patterns of the association. Results: A total of 800 participants were enrolled; 729 completed follow-up, and 69 developed DILI, resulting in a cumulative incidence of 9.4%. The risk of DILI was significantly higher in the pro-inflammatory group than in the anti-inflammatory group: OR = 2.17 (95% CI: 1.17–4.05) in Model 1, and OR = 2.19 (95% CI: 1.16–4.14) after adjustment; For every 1-unit increase in DII, the risk of liver injury increased by approximately 29% (OR = 1.29, 95% CI: 1.08–1.54). Results from L1 regularization were consistent, and effect modification was observed at the levels of sex and age. Conclusions: A higher Dietary Inflammatory Index (DII) was an independent risk factor for antituberculosis treatment-related liver injury in patients with drug-resistant tuberculosis. The risk of drug-induced liver injury (DILI) in the pro-inflammatory dietary group was approximately twice that in the anti-inflammatory dietary group. Identifying and modifying pro-inflammatory dietary patterns may help reduce the risk of DILI and improve the safety of antituberculosis treatment.
No takes yet. Share an insight, caveat, or question.
Guan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: